GluCurve Pet CGM
Diabetes Management in Cats and Dogs
Commercial LaunchRelaunch scheduled for January 2026 in Canada
Key Facts
Indication
Diabetes Management in Cats and Dogs
Phase
Commercial Launch
Status
Relaunch scheduled for January 2026 in Canada
Company
About ALR Technologies
ALR Technologies operates at the intersection of human and animal health, providing technology-enabled solutions for chronic disease management. Its core offering is the ALRT Diabetes Solution, an FDA-cleared, HIPAA-compliant remote care management platform that collects data from glucose meters and CGMs, features a patent-pending Predictive A1C algorithm, and includes FDA-cleared insulin dose adjustment tools. The company has expanded into the veterinary market with the GluCurve Pet CGM, which it is preparing to relaunch in Canada, and trades publicly on the OTCQB market under the ticker ALRTF.
View full company profile